Moderna, Inc. (MRNA) Capital expenditures 2016–2025
Moderna, Inc. (MRNA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$192.0MFY2025 · since FY2016: $33.1M → $192.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $192.0M | -81.7% |
| FY2024 | $1.1B | +48.7% |
| FY2023 | $707.0M | +76.8% |
| FY2022 | $400.0M | +40.8% |
| FY2021 | $284.0M | +317.6% |
| FY2020 | $68.0M | +112.5% |
| FY2019 | $32.0M | -69.7% |
| FY2018 | $105.8M | +81.1% |
| FY2017 | $58.4M | +76.2% |
| FY2016 | $33.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice